(Q79781724)

English

Efficacy and safety of enteric-coated mycophenolate sodium (myfortic) in de novo renal transplant recipients: results of a 12-month multicenter, open-label, prospective study

scientific article published on 01 June 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16797288%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Efficacy and safety of enteric-coated mycophenolate sodium (myfortic) in de novo renal transplant recipients: results of a 12-month multicenter, open-label, prospective study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16797288%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

B Vogt

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16797288%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

A Antoniadis

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16797288%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

M Klinger

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16797288%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

S Vitko

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16797288%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16797288%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16797288%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

38

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16797288%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16797288%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1301-1306

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16797288%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Long-term administration of enteric-coated mycophenolate sodium in kidney transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant patients: preliminary results from the myfortic prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Stable renal transplant recipients can be safely converted from MMF to enteric-coated mycophenolate sodium tablets: Interim results of a multicenter Latin American study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Safety assessment of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Efficacy and safety outcomes among de novo renal transplant recipients managed by C2 monitoring of cyclosporine a microemulsion: results of a 12-month, randomized, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Clinical validation studies of Neoral C(2) monitoring: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Gastrointestinal-specific patient-reported outcome instruments differentiate between renal transplant patients with or without GI complications

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2006.02.125

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2006.02.125

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16797288%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16797288%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79781724&oldid=1367229912"